Palantir’s Legal Setback Highlights Challenges in European Markets
Palantir loses legal battle in Switzerland, raising questions about its European market strategy.
Palantir loses legal battle in Switzerland, raising questions about its European market strategy.
European nations are distancing from Palantir due to security and ethical concerns.
Concerns over Palantir's role in NHS data management could impact patient privacy.